Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).

@article{Consoli2012LevetiracetamVC,
  title={Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).},
  author={Domenico Consoli and Dorotea Bosco and Paolo Postorino and Franco Galati and Massimiliano Plastino and G. F. Perticoni and Gian Andrea Ottonello and Bruno Passarella and Stefano Ricci and Giandomenico Neri and Danilo S Toni},
  journal={Cerebrovascular diseases},
  year={2012},
  volume={34 4},
  pages={282-9}
}
BACKGROUND Strokes are the leading cause of epileptic seizures in adults and account for 50% of seizures in those over the age of 65 years. The use of antiepileptic drugs to prevent recurrent poststroke seizures is recommended. METHODS One hundred and twenty-eight patients with poststroke seizures were randomly allocated to treatment with either levetiracetam (LEV) or sustained-release carbamazepine (CBZ) in a multicenter randomized open-label study. After a titration study phase (2 weeks… CONTINUE READING
Highly Cited
This paper has 474 citations. REVIEW CITATIONS

5 Figures & Tables

Topics

Statistics

0200400201320142015201620172018
Citations per Year

475 Citations

Semantic Scholar estimates that this publication has 475 citations based on the available data.

See our FAQ for additional information.